Serological Test News and Research

RSS

MP Biomedicals and A*STAR jointly develop rapid antibody test kit for COVID-19

MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research.

From MP Biomedicals, LLC 25 Jul 2020

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

A recent study published in the preprint server medRxiv in July 2020 shows that this is indeed possible. The development of this inexpensive but reliable and sensitive test could change the face of preventive measures for COVID-19 in low-resource settings.

17 Jul 2020

BATM provides business and trading update

BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, provides the following business and trading update.

26 Jun 2020

Seroprevalence of IgM and IgG against SARS-CoV-2 in China

A new study published in the journal Nature Medicine in June 2020 reports the seroprevalence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across China. This may help to understand the actual prevalence of the virus in the current pandemic.

10 Jun 2020

Siemens receives FDA approval for SARS-CoV-2 antibody test

Siemens Healthineers has announced that the U.S. Food and Drug Administration (FDA) had issued an Emergency Use Authorization for its total antibody test to detect the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies, including Immunoglobulin M (IgM) and Immunoglobulin G (IgG) in the blood.

3 Jun 2020

At-home finger prick COVID-19 antibody testing

The best way to estimate the actual prevalence of COVID-19 in the population is by antibody testing. A new study by scientists at Enable Biosciences and published on the preprint server medRxiv* in May 2020 reports the development of fast and sensitive antibody testing kits designed for at-home use. This could significantly boost the measurement of population prevalence of this infection and help understand whether it confers immunity to reinfection.

2 Jun 2020

ELISA and CLIA antibody tests for SARS-CoV-2 perform best in terms of sensitivity

Testing for those who have developed antibodies against the coronavirus can help tackle the ongoing COVID-19 pandemic. Now, a new study has identified all the antibody tests available for the coronavirus disease (COVID-19) to determine which performs better and is more accurate.

21 May 2020

SMART researchers awarded NMRC funding to develop rapid paper-based COVID-19 tests

Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, has received a grant from the National Medical Research Council COVID-19 Research fund for the acceleration of research and development of rapid paper-based serological and diagnostic tests for COVID-19.

18 May 2020

Study demonstrates dynamic and broad-scale immune alterations in COVID-19 patient

A new case report released on the preprint server medRxiv* provides a detailed longitudinal analysis of the immune response associated with a fatal case of coronavirus disease (COVID-19). It highlights the need for addressing the source of hyper inflammation in the treatment approach.

10 May 2020

New antibody test to identify individuals infected with COVID-19 virus

Several tests have been developed for detecting the genetic material of the SARS-CoV-2 coronavirus that causes COVID-19, but these generally only allow detection of the virus during acute infection.

25 Apr 2020

Antibodies to COVID-19 present in only 2 to 3 percent of population

This week on Monday (20th April 2020), in a press meet, the World Health Organization (WHO) Director-General said that only around 2 to 3 percent of the global population have antibodies that show they had been infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease.

22 Apr 2020

UC San Diego Health launches serological tests to detect past exposure to novel coronavirus

Clinical laboratory physicians and scientists at UC San Diego Health have launched a pair of serological tests that will look for novel coronavirus antibodies -- evidence in persons tested that they have previously been infected by SARS-CoV-2, the viral cause of COVID-19, even if they never experienced tell-tale symptoms.

18 Apr 2020

Study identifies two new viruses in Brazilian patients with suspected dengue

Two new species of viruses have been identified in blood samples taken from patients in Brazil's northern region who had similar symptoms to those of dengue or Zika, such as high fever, severe headache, rash and red skin spots.

17 Apr 2020

New blood test for antibodies in COVID-19 infected

The COVID-19 disease pandemic is raging across the world, costing tens of thousands of lives. Many countries have enforced widespread, if not universal lockdowns, to prevent the spread of the virus to new areas, carried by infected travelers.

14 Apr 2020

Immunizing with plasma to fight against COVID-19

Is it possible that the blood of those who have recovered from COVID-19 can help cure those who are now sick?

9 Apr 2020

New anti-COVID-19 system could potentially fight other viruses

The ongoing COVID-19 pandemic has sparked many research projects to meet the challenge of the virus and come up with measures to fight its activity. A new study published in the journal Cell Host & Microbe in April 2020 describes a novel system to help scientists understand the virus, including mutations, diagnose infections, and also to develop and evaluate vaccines more quickly.

8 Apr 2020

UC San Diego Health expands COVID-19 testing capacity

From the beginning, the ability of front line clinicians to test patients for COVID-19 -- to determine whether a person is infected with the disease-causing novel coronavirus, SARS-CoV-2 -- has been part and parcel of the pandemic.

6 Apr 2020

ATS publishes clinical guideline on laboratory diagnosis of fungal infections

The American Thoracic Society has published an official clinical guideline on laboratory diagnosis of fungal infections in pulmonary and critical care medicine in the Society's Aug. 30 American Journal of Respiratory and Critical Care Medicine.

30 Aug 2019

FDA approves first vaccine for prevention of dengue disease in endemic regions

The U.S. Food and Drug Administration announced today the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages 9 through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas.

6 Jun 2019

Previous dengue infection could protect against Zika-associated damage

The Zika virus outbreak in Latin America has affected over 60 million people up to now. The infection can have potentially fatal consequences for pregnant women and their unborn children: many children have subsequently been born with malformations of the head, or so-called microcephaly.

18 May 2019